Back

Market licensing of type 2 diabetes medicinal products based on patient-relevant hard outcomes: is there hope?

European Heart Journal - Cardiovascular Pharmacotherapy

5 January 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

Thomas A Schmidt
Thomas A Schmidt

Author

ESC 365 is supported by

novartis Explore sponsored resources